Health TrialsbyHealthPanel

Comparative Effects of ESP Block and EOIP Block on Postoperative Respiratory Recovery Following Liver Resection

ConditionsLiver ResectionUpper Abdominal Surgeries
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMenoufia University

About this trial

This study evaluates respiratory recovery as a multidimensional construct using clinically relevant and measurable parameters, including LUS, diaphragmatic excursion, oxygen requirement, and PPCs.

The investigators hypothesize that bilateral ESP block improves postoperative respiratory function compared with EOIP block following open hepatic surgery. The investigators further hypothesize that this improvement is mediated, in part, by superior analgesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients aged 18-75 years

Adult with American Society of Anesthesiologists (ASA) physical status I-III

Scheduled for elective hepatic surgery via upper abdominal incisions will be eligible.

All participants will be required to understand the Numeric Rating Scale (NRS) and provide informed consent.

Disqualifiers

Patient refusal

Coagulopathy (INR>1.4 or platelet count<8 x 104)

Contraindications to fascial plane blocks

Infection at the puncture site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-guided bilateral external oblique intercostal plane (EOIP) block

    Procedure/Surgery

    Bilateral ESP block * after induction of general anesthesia and before surgical incision. * T7 or T8 transverse process, selected consistently by protocol. * high-frequency linear probe when feasible; curvilinear probe in larger habitus. In-plane cranial-to-caudal or caudal-to-cranial approach to the fascial plane deep to erector spinae muscle and superficial to the transverse process. * Injectate: 20 mL of 0.25% bupivacaine per side after negative aspiration; hydrodissection used to confirm correct plane. Bilateral EOIP block * after induction of general anesthesia and before surgical incision. * ultrasound-guided injection into the fascial plane between the external oblique muscle and the intercostal muscle/external intercostal membrane near the 6th-8th intercostal spaces on each side, following the institutional standardized approach. * Injectate: 20 mL of 0.25% bupivacaine per side Safter negative aspiration.

  • Ultrasound-guided bilateral erector spinae plane (ESP) block

    Procedure/Surgery

    An ultrasound-guided bilateral ESP block will be performed after induction of general anaesthesia and before surgical incision. The block will be administered at the T7 or T8 transverse process using an in-plane ultrasound-guided approach. Twenty millilitres of 0.25% bupivacaine will be injected on each side into the fascial plane deep to the erector spinae muscle and superficial to the transverse process after negative aspiration. Correct spread of local anaesthetic will be confirmed by hydrodissection.

Treatment groups

116 Participants
are divided into 2 treatment groups
Group A: The external oblique intercostal plane (EOIP) blockActive comparator 1 intervention
Group B: The erector spinae plane (ESP) blockActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Right diaphragmatic excursion

Right diaphragmatic excursion will be measured during quiet tidal breathing in the semi-recumbent position using M-mode ultrasonography through a right subcostal hepatic acoustic window. Three consecutive respiratory cycles will be recorded and averaged at each assessment measured in cm.

Time frame
Baseline, and 1, 6, and 24 hours after surgery.

Secondary outcomes

1

Mean postoperative pain intensity at rest, during coughing or deep breathing

Postoperative pain intensity at rest will be assessed using the Numeric Rating Scale NRS score 0-10. Postoperative pain intensity during coughing or deep breathing will be assessed using the Numeric Rating Scale NRS score 0-10.

Time frame
Pain scores at rest (PACU 30 minutes, 2, 6, 12, and 24 hours) and during coughing or deep breathing (6, 12, and 24 hours).
2

Mean cumulative postoperative opioid consumption and Mean intraoperative opioid consumption

Total cumulative opioid consumption during the first 24 postoperative hours. Measured in Morphine milligram equivalents (MME). Total opioid administered during the intraoperative period from induction of anesthesia until completion of surgery. Measured in Morphine milligram equivalents (MME).

Time frame
First 24 postoperative hours.
3

Number of participants requiring supplemental oxygen

Number of participants requiring supplemental oxygen or escalation of oxygen therapy beyond standard postoperative care to maintain peripheral oxygen saturation (SpO₂) ≥94%, according to institutional postoperative care protocols. Number of participants (%)

Time frame
First 24 postoperative hours.
4

Number of participants with early postoperative pulmonary complications

Number of participants who develop early postoperative pulmonary complications within 7 days after surgery, including clinically significant atelectasis. Number of participants (%)

Time frame
Within 7 postoperative days.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Menoufia University

Lead sponsor

National Liver Institute, Egypt

Collaborator

Source ClinicalTrials.gov
Apply now